Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbial metabolites in health and disease: Navigating the unknown in search of function
Kristina Martinez, Vanessa Leone, Eugene B. Chang
Journal of Biological Chemistry (2017) Vol. 292, Iss. 21, pp. 8553-8559
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine
Hisako Kayama, Ryu Okumura, Kiyoshi Takeda
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 23-48
Open Access | Times Cited: 489
New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 623-639
Closed Access | Times Cited: 409
Microbiome–microglia connections via the gut–brain axis
Reem Abdel-Haq, Johannes C. M. Schlachetzki, Christopher K. Glass, et al.
The Journal of Experimental Medicine (2018) Vol. 216, Iss. 1, pp. 41-59
Open Access | Times Cited: 363
Quality assurance procedures for mass spectrometry untargeted metabolomics. a review
Danuta Dudzik, Cecilia Barbas-Bernardos, Antonia Garcı́a, et al.
Journal of Pharmaceutical and Biomedical Analysis (2017) Vol. 147, pp. 149-173
Closed Access | Times Cited: 303
Microbiota in pancreatic health and disease: the next frontier in microbiome research
Ryan M. Thomas, Christian Jobin
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 1, pp. 53-64
Closed Access | Times Cited: 245
The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice
Kunpeng Wu, Yan Yuan, Huihui Yu, et al.
Blood (2020) Vol. 136, Iss. 4, pp. 501-515
Open Access | Times Cited: 223
Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation
Tim Hendrikx, Bernd Schnabl
Journal of Internal Medicine (2019) Vol. 286, Iss. 1, pp. 32-40
Open Access | Times Cited: 159
Gut Microbiota Metabolism and Interaction with Food Components
Pamela Vernocchi, Federica Del Chierico, Lorenza Putignani
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3688-3688
Open Access | Times Cited: 152
Gut Microbiota Metabolites in Major Depressive Disorder—Deep Insights into Their Pathophysiological Role and Potential Translational Applications
Miguel Á. Ortega, Miguel Ángel Alvarez‐Mon, Cielo García‐Montero, et al.
Metabolites (2022) Vol. 12, Iss. 1, pp. 50-50
Open Access | Times Cited: 82
Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
Éloi Gagnon, Patricia L. Mitchell, Hasanga D. Manikpurage, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 46
Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective
Mireia Vallès-Colomer, Cristina Menni, Sarah Berry, et al.
Nature Medicine (2023) Vol. 29, Iss. 3, pp. 551-561
Closed Access | Times Cited: 44
Microbiome-Driven Therapeutics: From Gut Health to Precision Medicine
Muneer Yaqub, Aashika Jain, Chinedu Eucharia Joseph, et al.
Gastrointestinal Disorders (2025) Vol. 7, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function
Suzanne R. Sharpton, Veeral Ajmera, Rohit Loomba
Clinical Gastroenterology and Hepatology (2018) Vol. 17, Iss. 2, pp. 296-306
Open Access | Times Cited: 152
Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease
Suzanne R. Sharpton, Bernd Schnabl, Rob Knight, et al.
Cell Metabolism (2020) Vol. 33, Iss. 1, pp. 21-32
Open Access | Times Cited: 129
Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates
Ashiq Khan, Zitong Ding, Muhammad Ishaq, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 3, pp. 818-833
Open Access | Times Cited: 83
Gut‐liver axis‐mediated mechanism of liver cancer: A special focus on the role of gut microbiota
Naoko Ohtani, Eiji Hara
Cancer Science (2021) Vol. 112, Iss. 11, pp. 4433-4443
Open Access | Times Cited: 78
Role of intestinal microbiota and metabolites in inflammatory bowel disease
Lina Dong, Mu Wang, Jian Guo, et al.
Chinese Medical Journal (2019) Vol. 132, Iss. 13, pp. 1610-1614
Open Access | Times Cited: 77
Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis
Xia Liu, Runzhou Sun, Zhaozhen Li, et al.
Archives of Biochemistry and Biophysics (2021) Vol. 711, pp. 109019-109019
Closed Access | Times Cited: 73
Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC
Ibrahim Javed, Zhenzhen Zhang, Jozef Adamčík, et al.
Advanced Science (2020) Vol. 7, Iss. 18
Open Access | Times Cited: 69
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy
Alexandria P. Cogdill, Pierre Olivier Gaudreau, Reetakshi Arora, et al.
Trends in Immunology (2018) Vol. 39, Iss. 11, pp. 900-920
Open Access | Times Cited: 82
Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function
Amedeo Amedei, Lucia Morbidelli
Molecules (2019) Vol. 24, Iss. 21, pp. 3992-3992
Open Access | Times Cited: 70
Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis
Jennifer Damman, Eduardo A. Rodríguez, Ahmad H. Ali, et al.
Alimentary Pharmacology & Therapeutics (2018) Vol. 47, Iss. 7, pp. 886-895
Open Access | Times Cited: 69
Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework
Ayesha Shah, Graeme A. Macdonald, Mark Morrison, et al.
The American Journal of Gastroenterology (2020) Vol. 115, Iss. 6, pp. 814-822
Open Access | Times Cited: 58
Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity
Angélica Cruz-Lebrón, Ramona Johnson, Claire Mazahery, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 53
Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges
Laura Marinela Ailioaie, Gerhard Litscher
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4942-4942
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top